Jennifer H. Lofland - Concepedia

Author

Jennifer H. Lofland

Janssen (United States)ORCID

Also Known As

J Lofland, J. Lofland, J.H. Lofland, Jennifer H Lofland, Jennifer H. Lofland, Jennifer Lofland

116

Publications

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Thomas Jefferson University Janssen Scientific Affairs (United States)Incyte (United States)Stony Brook University

About

Jennifer H. Lofland is an author at Janssen (United States) specializing in medicine, outcomes research, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	275
2	Public Health	2	2	117
3	Education	1	1	66
4	Health Sciences	1	1	46
5	Epidemiology	1	1	38

Jennifer H. Lofland

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Quality‐of‐Life Differences Between Patients With Episodic and Transformed Migraine Dennis Meletiche, Jennifer H. Lofland, William B. Young Headache The Journal of Head and Face Pain	2001	163
Changes in Resource Use and Outcomes for Patients With Migraine Treated With Sumatriptan Jennifer H. Lofland, Nelda E. Johnson, Alice S. Batenhorst, Archives of Internal Medicine	1999	109
Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs Jennifer H. Lofland, Phaedra Johnson, Mike Ingham, Patient Preference and Adherence	2017	98
Direct Health Care Insurer and Out-of-Pocket Expenditures of Inflammatory Bowel Disease: Evidence from a US National Survey Candace Gunnarsson, Jie Chen, John A. Rizzo, Digestive Diseases and Sciences Health Insurance ReformHealth EconomicsHealth PolicyHealth InsuranceHealth Financing	2012	79
Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis. Chenglong Han, Jennifer H. Lofland, N. Zhao, PubMed	2011	74
Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis Jennifer H. Lofland, Suzanne M. Touch, John O’Connor, Clinical Therapeutics VaccinationPreventive MedicineCost-effectiveness AnalysisPediatricsRespiratory Infection	2000	66
Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus Melinda Kedves, Fruzsina Kósa, Péter Kunovszki, Lara D. Veeken	2020	59
Different Approaches To Valuing the Lost Productivity of Patients with Migraine Jennifer H. Lofland, Julie Locklear, Kevin D. Frick PharmacoEconomics ProductivityDifferent ApproachesCluster HeadacheOutcomes ResearchRehabilitation	2001	48
Cost-Effectiveness and Cost-Benefit of Sumatriptan in Patients With Migraine Jennifer H. Lofland, Susan S. Kim, Alice S. Batenhorst, Mayo Clinic Proceedings Cluster HeadachePain ResearchHealth SciencesPain MedicinePharmacoeconomics	2001	46
Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States Furaha Kariburyo, Lin Xie, Janvi Sah, Journal of Medical Economics	2019	41

Page 1